Latrunculin B

CAS : 76343-94-7

Ref. 3D-BDA34394

Informations sur le produit

• Nom: Latrunculin B
• Synonymes: 2-Thiazolidinone, 4-(15-hydroxy-5,10-dimethyl-3-oxo-2,14-dioxabicyclo[11.3.1]heptadeca-4,8-dien-15-yl)-, [1R-[1R*,4Z,8Z,10S*,13R*,15R*(R*)]]-, 2-Thiazolidinone, 4-[(1R,4Z,8Z,10S,13R,15R)-15-hydroxy-5,10-dimethyl-3-oxo-2,14-dioxabicyclo[11.3.1]heptadeca-4,8-dien-15-yl]-, (4R)-, 2,13-Dioxabicyclo[11.3.1]heptadecane, 2-thiazolidinone deriv., (4R)-4-[(1R,4Z,8Z,10S,13R,15R)-15-Hydroxy-5,10-dimethyl-3-oxo-2,14-dioxabicyclo[11.3.1]heptadeca-4,8-dien-15-yl]-2-thiazolidinone

Description

Latrunculin B is a natural compound that acts as a potent inhibitor of actin polymerization. It blocks the polymerization of actin monomers, leading to cell lysis and cell death. Latrunculin B has been shown to increase the motility of pluripotent stem cells and induce angiogenesis in vivo. However, this drug has no effect on the growth or survival of tumor cells in vitro. The mechanism by which latrunculin B induces these effects is still unclear and may be related to its ability to inhibit transcriptional regulation and protein synthesis in a model system. Latrunculin B has also been shown to be an inhibitor of P-glycoprotein (P-gp), one of the major drug efflux transporters found in human cells. This drug may have potential as a substrate for P-gp inhibitors that are being developed for cancer chemotherapy.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 395.51 g/mol
• Formule: C₂₀H₂₉NO₅S
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder